These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34519834)

  • 21. Field safety notices released by manufacturers in cases of failure of products for infection testing: analysis of cases reported to the BfArM between 2005 and 2007.
    Siekmeier R; Lisson K; Wetzel D
    Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):175-83. PubMed ID: 21147647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Requirements for drug approval and additional benefits assessment: Regulatory aspects and experiences].
    Broich K; Löbker W; Schulte A; Beinlich P; Müller T
    Nervenarzt; 2016 Apr; 87(4):376-85. PubMed ID: 27003322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [What potential and added value do DiGA offer for primary care?-Results of a survey of general practitioners in Germany].
    Wangler J; Jansky M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Dec; 65(12):1334-1343. PubMed ID: 36269336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interoperability in healthcare: also prescribed for digital health applications (DiGA)].
    Weber S; Heitmann KU
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1262-1268. PubMed ID: 34532746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Technology assessment of digital health applications for reimbursement decisions].
    Jeindl R; Wild C
    Wien Med Wochenschr; 2024 Mar; 174(3-4):44-52. PubMed ID: 34529150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experiences and recommendations of the German Federal Institute for Drugs and Medical Devices (BfArM) concerning clinical investigation of medical devices and the evaluation of serious adverse events (SAE)].
    Renisch B; Lauer W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Dec; 57(12):1368-75. PubMed ID: 25376539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ["Alternative study designs" for the evaluation of digital health applications - a real alternative?].
    Gensorowsky D; Lampe D; Hasemann L; Düvel J; Greiner W
    Z Evid Fortbild Qual Gesundhwes; 2021 Apr; 161():33-41. PubMed ID: 33642251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Digital respiratory sleep medicine-part I: diagnosis].
    Schöbel C; Woehrle H
    Somnologie (Berl); 2020; 24(3):138-144. PubMed ID: 32904614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DiGA - A Chance for the German Healthcare System.
    Sauermann S; Herzberg J; Burkert S; Habetha S
    J Eur CME; 2022; 11(1):2014047. PubMed ID: 34992948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Digital Health Applications: A Qualitative Study of Approaches to Improve Access to Statutory Health Insurance].
    Düvel JA; Gensorowsky D; Hasemann L; Greiner W
    Gesundheitswesen; 2022 Jan; 84(1):64-74. PubMed ID: 33636736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Russ H; Busta S; Jost B; Bethke TD
    Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incident reporting to BfArM - regulatory framework, results and challenges.
    Seidel R; Stößlein E; Lauer W
    Biomed Tech (Berl); 2016 Apr; 61(2):239-48. PubMed ID: 27028733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Transducer Hygiene sufficient when Vaginal Probes are used in the Clinical Routine?
    Merz E
    Ultraschall Med; 2016 Apr; 37(2):137-9. PubMed ID: 27058433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with post-market surveillance of in-vitro diagnostic medical devices for lay use in Germany.
    Siekmeier R; Lütz J
    Clin Chem Lab Med; 2007; 45(3):396-401. PubMed ID: 17378740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Digital health applications-patient-centric care with disruptive potential].
    Ryll B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1207-1212. PubMed ID: 34477883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Are blood glucose analyzers safe? Experiences of the BfArM based on all notifications received until end of 2005].
    Siekmeier R; Lütz J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Dec; 49(12):1212-8. PubMed ID: 17149661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Market surveillance of in vitro diagnostics by the BfArM until end 2010: how safe are products for tumor diagnostics?
    Siekmeier R; Wetzel D
    Adv Exp Med Biol; 2013; 755():385-96. PubMed ID: 22826091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.